Source: China – South China Morning PostA genomic tool developed by researchers in China could transform early detection and personalised treatment for pancreatic cancer – one of the deadliest forms of the disease.
Known as the “king of cancers”, pancreatic cancer is characterised by late diagnosis, rapid metastasis and limited treatment targets. It ranks as the sixth leading cause of global cancer mortality, according to the Global Cancer Observatory.
However, the “Uni-C” single-cell “multiomics” technology developed by the Chinese…Read More